![Mechanical heart valve patients switched to DOACs during COVID-19 pandemic to be reviewed 'urgently' - The Pharmaceutical Journal Mechanical heart valve patients switched to DOACs during COVID-19 pandemic to be reviewed 'urgently' - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2021/12/xarelto-doacs-ss-21-343x194.jpg)
Mechanical heart valve patients switched to DOACs during COVID-19 pandemic to be reviewed 'urgently' - The Pharmaceutical Journal
![Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d952750d-b7b3-4ef0-aee2-5d60b3aab754/gr4.jpg)
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
![PROACT Xa Trial to Assess Non-Warfarin Anticoagulation After AVR With a Mechanical Valve – Consult QD PROACT Xa Trial to Assess Non-Warfarin Anticoagulation After AVR With a Mechanical Valve – Consult QD](https://3pw8zx30ta4c3jegjv14ssuv-wpengine.netdna-ssl.com/wp-content/uploads/sites/2/2020/04/20-HRT-019-anticoagulation-650x450-1-650x450.jpg)
PROACT Xa Trial to Assess Non-Warfarin Anticoagulation After AVR With a Mechanical Valve – Consult QD
![Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy | SpringerLink Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40256-021-00520-7/MediaObjects/40256_2021_520_Fig2_HTML.png)
Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy | SpringerLink
![Effectiveness and Safety of Off-label Dosing of Non–vitamin K Antagonist Anticoagulant for Atrial Fibrillation in Asian Patients | Scientific Reports Effectiveness and Safety of Off-label Dosing of Non–vitamin K Antagonist Anticoagulant for Atrial Fibrillation in Asian Patients | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-58665-5/MediaObjects/41598_2020_58665_Fig1_HTML.png)
Effectiveness and Safety of Off-label Dosing of Non–vitamin K Antagonist Anticoagulant for Atrial Fibrillation in Asian Patients | Scientific Reports
![AHA 2020: Rivaroxaban comparable to warfarin for patients with atrial fibrillation and prosthetic valves - Cardiovascular News AHA 2020: Rivaroxaban comparable to warfarin for patients with atrial fibrillation and prosthetic valves - Cardiovascular News](https://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2020/11/Berwanger.jpg)
AHA 2020: Rivaroxaban comparable to warfarin for patients with atrial fibrillation and prosthetic valves - Cardiovascular News
![ACC/AHA Versus ESC Guidelines on Prosthetic Heart Valve Management: JACC Guideline Comparison - ScienceDirect ACC/AHA Versus ESC Guidelines on Prosthetic Heart Valve Management: JACC Guideline Comparison - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109719304929-fx1.jpg)
ACC/AHA Versus ESC Guidelines on Prosthetic Heart Valve Management: JACC Guideline Comparison - ScienceDirect
![China OEM China Festo Mechanical Valve - Mechanical Valve VM200 series – Blch factory and suppliers | Blch Pneumatic China OEM China Festo Mechanical Valve - Mechanical Valve VM200 series – Blch factory and suppliers | Blch Pneumatic](https://www.blpneumatic.com/uploads/74ebf198.png)
China OEM China Festo Mechanical Valve - Mechanical Valve VM200 series – Blch factory and suppliers | Blch Pneumatic
![Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis - American Journal of Cardiology Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis - American Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a6dbf201-e3de-48d0-bbb5-f2ca7f59b156/gr1_lrg.jpg)
Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis - American Journal of Cardiology
![PDF) Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study PDF) Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study](https://i1.rgstatic.net/publication/309593794_Trial_design_Rivaroxaban_for_the_prevention_of_major_cardiovascular_events_after_transcatheter_aortic_valve_replacement_Rationale_and_design_of_the_GALILEO_study/links/5e582ceda6fdccbeba0795a0/largepreview.png)
PDF) Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study
![Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/0a1b965e-4e95-4c3e-8621-b2ad1de72793/28ga01.jpg)
Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology
![Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2010d792-b36c-4308-adf8-852e0a2a41ec/gr4_lrg.jpg)